4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-18-034303
Senior VP - CCO sold 14,455 shares at an average $9.05 ($130,840)
- Senior VP - CCO acquired 12,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Powell Lynne Senior VP - CCO | 2018-11-21 | Option exercise | +12,000 | $3.22 | $38,640 | 14,455 | D: show line 1 in the form |
| Powell Lynne Senior VP - CCO | 2018-11-21 | Sale | −12,000 | $9.06 | $108,720 | 2,455 | D: show line 2 in the form |
| Powell Lynne Senior VP - CCO | 2018-11-21 | Sale | −2,455 | $9.01 | $22,120 | 0 | D: show line 3 in the form |
| Open-market sales · 14,455 sh · avg $9.05 · $130,840 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Powell Lynne Senior VP - CCO | 2018-11-21 | Option exercise · Emp. Stock Option (Right to Buy) | −12,000 | 101,427 | D: show line 4 in the form |
Loading xslF345X03/form4.xml…